Related Experiment Videos
Halothane hepatitis and prompt resolution with methionine therapy: case report
1Department of Surgery, Waikato Hospital, Hamilton.
The New Zealand Medical Journal
|August 10, 1988
Summary
Halothane-induced hepatitis occurred in a woman post-gastric surgery. Methionine therapy effectively resolved her jaundice and improved liver function tests.
Area of Science:
- Hepatology
- Anesthesiology
- Gastroenterology
Background:
- Halothane, an inhaled anesthetic, is known for rare but severe hepatotoxicity.
- Morbid obesity is a risk factor for various surgical complications, including potential liver issues.
Observation:
- A middle-aged woman developed progressive jaundice and abnormal liver function tests over five weeks following gastric surgery for morbid obesity.
- The patient had received halothane anesthesia during the surgical procedure.
Findings:
- The clinical presentation was consistent with halothane-induced hepatitis.
- Liver function abnormalities, including elevated bilirubin, showed a marked improvement after initiating methionine treatment.
Implications:
- This case highlights the importance of considering halothane hepatotoxicity in patients with unexplained liver dysfunction post-anesthesia.
- Methionine may be a beneficial therapeutic agent in managing halothane-induced liver injury.
- Early recognition and prompt treatment are crucial for favorable outcomes in anesthetic-related hepatitis.